TAK-225

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameTAK-225
Drug Alias NameTAK-225
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPlatelet activating factor receptor antagonistsLeukotriene receptor antagonistsEndothelin receptor antagonists
TargetsLeukotriene receptorEndothelin receptorPlatelet activating factor receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsAsthma

Other Information

ATC CodeN/A
Related LinksN/A